They emerge at night, while we sleep unaware, growing and spreading out as quickly as they can. And they are deadly. In a surprise finding that was recently published in Nature Communications, Weizmann Institute of Science researchers showed that nighttime is the right time for cancer to grow and spread in the body. Their findings suggest that administering certain treatments in time with the body's day-night cycle could boost their efficiency.
This finding arose out of an investigation into the relationships between different receptors in the cell – a complex network that we still do not completely understand. The receptors – protein molecules on the cell's surface or within cells – take in biochemical messages secreted by other cells and pass them on into the cell's interior. The scientists, led by Dr. Mattia Lauriola, a postdoctoral fellow in the research group of Prof. Yosef Yarden of the Weizmann Institute's Biological Regulation Department, working together with Prof. Eytan Domany of the Physics of Complex Systems Department, focused on two particular receptors. The first, the epidermal growth factor receptor, EGFR, promotes the growth and migration of cells, including cancer cells. The second binds to a steroid hormone called a glucocorticoid (GC). Glucocorticoids play a role in maintaining the body's energy levels during the day, as well as the metabolic exchange of materials. It is often called the stress hormone because its levels rise in stressful situations, rapidly bringing the body to a state of full alert.
With multiple receptors, the cell receives all sorts of messages at once, and some of these messages can take precedence over others. In the experiment, Lauriola and Yarden found that cell migration – the activity promoted by the EGF receptor – is suppressed when the GC receptor is bound to its steroid messenger.
Since the steroid levels peak during waking hours and drop off during sleep, the scientists asked how this might affect the second receptor – EGFR. Checking the levels of this activity in mice, they found that there was a significant difference: This receptor is much more active during sleep and quiescent during waking hours.
How relevant are these findings for cancers, particularly those which use the EGF receptors to grow and spread? To find out, the scientists gave Lapatinib – one of the new generation of cancer drugs – to mouse models of cancer. This drug, used to treat breast cancer, is designed to inhibit EGFR, and thus to prevent the growth and migration of the cancer cells. In the experiment, they gave the mice the drug at different times of day. The results revealed significant differences between the sizes of tumors in the different groups of mice, depending on whether they had been given the drug during sleep or waking hours. The experimental findings suggest that it is indeed the rise and fall in the levels of the GC steroids over the course of 24 hours that hinder or enable the growth of the cancer.
The conclusion, say the scientists, is that it could be more efficient to administer certain anticancer drugs at night.
"It seems to be an issue of timing," says Yarden. "Cancer treatments are often administered in the daytime, just when the patient's body is suppressing the spread of the cancer on its own. What we propose is not a new treatment, but rather a new treatment schedule for some of the current drugs."
Explore further: New approaches to cell study contributes to cancer research
More information: Nature Communications, http://ift.tt/1vGNp2E full/ncomms6073.html
Medical Xpress on facebook
Related Stories
New approaches to cell study contributes to cancer research
Sep 12, 2014
At Ryerson, some of our top researchers are committed to finding out how cells function, and to building our knowledge of the basic science of cellular function while investigating diseases and the potential ...
New ways to treat hormone receptor-positive breast cancer
Aug 12, 2014
A leading scientist based at Keele University in North Staffordshire has been awarded a grant worth around £20,000 by research charity Breast Cancer Campaign to find new ways to treat hormone receptor-positive breast cancer, ...
Researchers develop new anticancer peptide vaccines and inhibitors
Sep 24, 2014
(Medical Xpress)—Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort led by investigators at The Ohio State University Comprehensive ...
Carcinogenic role of a protein in liver decoded
Sep 01, 2014
The human protein EGFR controls cell growth. It has mutated in case of many cancer cells or exists in excessive numbers. For this reason it serves as a point of attack for target-oriented therapies. A study ...
Total darkness at night is key to success of breast cancer therapy
Jul 25, 2014
Exposure to light at night, which shuts off nighttime production of the hormone melatonin, renders breast cancer completely resistant to tamoxifen, a widely used breast cancer drug, says a new study by Tulane University School ...
Recommended for you
'JAKing' up blood cancers, one cell at a time
14 minutes ago
A solitary cell containing a unique abnormality can result in certain types of blood cancers known as myeloproliferative neoplasms (MPN), according to a study published in The Journal of Experimental Medicine.
Link between breast implants and cancer under investigation
17 minutes ago
An international research group including Viennese pathologist Lukas Kenner has reviewed cases of possible association between breast implants and a form of lymphoma that may develop tumors at a later stage. The researchers ...
Mother of two volunteers to aid study seeking DNA patterns for breast cancer
Oct 03, 2014
After having two children in her 30s, Brianna Hinojosa-Flores had been vigilant about getting mammograms and performing breast self-exams, as suggested by her gynecologist. But when she ran for a congressional ...
Lung cancer screening found cost-effective for Medicare
Oct 03, 2014
(HealthDay)—Low-dose computed tomography (LDCT) is a low-cost and cost-effective strategy for screening Medicare beneficiaries for lung cancer, according to a study published in the August issue of American He ...
More women having reconstruction surgery after breast cancer treatment
Oct 03, 2014
(HealthDay)—A growing number of breast cancer patients in the United States are having breast reconstruction surgery immediately after breast removal (mastectomy), a new study shows.
New visualization software uncovers cancer subtypes
Oct 03, 2014
(Medical Xpress)—Much of biomedical research these days is about big data—collecting and analyzing vast, detailed repositories of information about health and disease. These data sets can be treasure ...
User comments
© Medical Xpress 2011-2014, Science X network
They emerge at night, while we sleep unaware, growing and spreading out as quickly as they can. And they are deadly. In a surprise finding that was recently published in Nature Communications, Weizmann Institute of Science researchers showed that nighttime is the right time for cancer to grow and spread in the body. Their findings suggest that administering certain treatments in time with the body's day-night cycle could boost their efficiency.
This finding arose out of an investigation into the relationships between different receptors in the cell – a complex network that we still do not completely understand. The receptors – protein molecules on the cell's surface or within cells – take in biochemical messages secreted by other cells and pass them on into the cell's interior. The scientists, led by Dr. Mattia Lauriola, a postdoctoral fellow in the research group of Prof. Yosef Yarden of the Weizmann Institute's Biological Regulation Department, working together with Prof. Eytan Domany of the Physics of Complex Systems Department, focused on two particular receptors. The first, the epidermal growth factor receptor, EGFR, promotes the growth and migration of cells, including cancer cells. The second binds to a steroid hormone called a glucocorticoid (GC). Glucocorticoids play a role in maintaining the body's energy levels during the day, as well as the metabolic exchange of materials. It is often called the stress hormone because its levels rise in stressful situations, rapidly bringing the body to a state of full alert.
With multiple receptors, the cell receives all sorts of messages at once, and some of these messages can take precedence over others. In the experiment, Lauriola and Yarden found that cell migration – the activity promoted by the EGF receptor – is suppressed when the GC receptor is bound to its steroid messenger.
Since the steroid levels peak during waking hours and drop off during sleep, the scientists asked how this might affect the second receptor – EGFR. Checking the levels of this activity in mice, they found that there was a significant difference: This receptor is much more active during sleep and quiescent during waking hours.
How relevant are these findings for cancers, particularly those which use the EGF receptors to grow and spread? To find out, the scientists gave Lapatinib – one of the new generation of cancer drugs – to mouse models of cancer. This drug, used to treat breast cancer, is designed to inhibit EGFR, and thus to prevent the growth and migration of the cancer cells. In the experiment, they gave the mice the drug at different times of day. The results revealed significant differences between the sizes of tumors in the different groups of mice, depending on whether they had been given the drug during sleep or waking hours. The experimental findings suggest that it is indeed the rise and fall in the levels of the GC steroids over the course of 24 hours that hinder or enable the growth of the cancer.
The conclusion, say the scientists, is that it could be more efficient to administer certain anticancer drugs at night.
"It seems to be an issue of timing," says Yarden. "Cancer treatments are often administered in the daytime, just when the patient's body is suppressing the spread of the cancer on its own. What we propose is not a new treatment, but rather a new treatment schedule for some of the current drugs."
Explore further: New approaches to cell study contributes to cancer research
More information: Nature Communications, http://ift.tt/1vGNp2E full/ncomms6073.html
Medical Xpress on facebook
Related Stories
New approaches to cell study contributes to cancer research
Sep 12, 2014
At Ryerson, some of our top researchers are committed to finding out how cells function, and to building our knowledge of the basic science of cellular function while investigating diseases and the potential ...
New ways to treat hormone receptor-positive breast cancer
Aug 12, 2014
A leading scientist based at Keele University in North Staffordshire has been awarded a grant worth around £20,000 by research charity Breast Cancer Campaign to find new ways to treat hormone receptor-positive breast cancer, ...
Researchers develop new anticancer peptide vaccines and inhibitors
Sep 24, 2014
(Medical Xpress)—Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort led by investigators at The Ohio State University Comprehensive ...
Carcinogenic role of a protein in liver decoded
Sep 01, 2014
The human protein EGFR controls cell growth. It has mutated in case of many cancer cells or exists in excessive numbers. For this reason it serves as a point of attack for target-oriented therapies. A study ...
Total darkness at night is key to success of breast cancer therapy
Jul 25, 2014
Exposure to light at night, which shuts off nighttime production of the hormone melatonin, renders breast cancer completely resistant to tamoxifen, a widely used breast cancer drug, says a new study by Tulane University School ...
Recommended for you
'JAKing' up blood cancers, one cell at a time
14 minutes ago
A solitary cell containing a unique abnormality can result in certain types of blood cancers known as myeloproliferative neoplasms (MPN), according to a study published in The Journal of Experimental Medicine.
Link between breast implants and cancer under investigation
17 minutes ago
An international research group including Viennese pathologist Lukas Kenner has reviewed cases of possible association between breast implants and a form of lymphoma that may develop tumors at a later stage. The researchers ...
Mother of two volunteers to aid study seeking DNA patterns for breast cancer
Oct 03, 2014
After having two children in her 30s, Brianna Hinojosa-Flores had been vigilant about getting mammograms and performing breast self-exams, as suggested by her gynecologist. But when she ran for a congressional ...
Lung cancer screening found cost-effective for Medicare
Oct 03, 2014
(HealthDay)—Low-dose computed tomography (LDCT) is a low-cost and cost-effective strategy for screening Medicare beneficiaries for lung cancer, according to a study published in the August issue of American He ...
More women having reconstruction surgery after breast cancer treatment
Oct 03, 2014
(HealthDay)—A growing number of breast cancer patients in the United States are having breast reconstruction surgery immediately after breast removal (mastectomy), a new study shows.
New visualization software uncovers cancer subtypes
Oct 03, 2014
(Medical Xpress)—Much of biomedical research these days is about big data—collecting and analyzing vast, detailed repositories of information about health and disease. These data sets can be treasure ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment